Oral Contraceptives Protect Against Ovarian, Endometrial Cancer
Oral contraceptives have a lasting protective effect against ovarian and endometrial cancer, according to a new study.
Oral contraceptives have a lasting protective effect against ovarian and endometrial cancer, according to a new study.
Use of any and combined hormonal contraceptives is associated with a reduction in the risk for severe asthma exacerbation.
Researchers found that 65.3% of women aged 15 to 49 years in the United States were currently using contraception in 2017 to 2019.
By the end of the 6th year, Mirena should be removed and replaced if continued use is desired.
Long-acting reversible contraception, such as hormonal and non-hormonal intrauterine devices (IUDs) and hormonal implants, have been proven safe and effective for adolescent patients.
Minors’ ability to consent to contraception varies from state to state, but right to consent does not necessarily mean access to contraception.
Unintended pregnancies were reported 7 times more often by patients who took antibiotics compared with those who took control medicines.
The permanent birth control device Essure is associated with higher rates of chronic lower abdominal or pelvic pain and abnormal uterine bleeding compared with tubal ligation.
Two-thirds of girls seen in pediatric emergency department interested in discussing contraception.
Findings based on comparison to hormonal intrauterine devices.